Medilines Distributors, Inc., a leading distributor of medical equipment in the country, has established strong and strategic partnerships with top global suppliers to be able to deliver state-of-the-art equipment to various health facilities in the country.

According to Medilines, partnering with the right principal is of utmost importance in their industry, as well as in their mission to provide all Filipinos with access to healthcare facilities with world-class medical equipment.

“Our long-standing relationships with these global industry leaders will continue to strengthen our market position in the medical equipment distribution space in the Philippines,” Medilines Chairman Virgilio Villar said.

“The established operations of our principals in the Philippines also enable our company’s operations to be lean and efficient,” he added.

Medilines is focused on three healthcare categories: diagnostic imaging, dialysis, and cancer therapy.  It has been doing business with multinational medical device companies who are leading brands in the named categories, namely, Siemens Healthineers, B. Braun Avitum Philippines, and Varian Medical Systems, respectively, for the past several years.

By participating in these categories, Medilines’ portfolio of critical medical equipment is able to diagnose and treat the most prevalent diseases in the Philippines, which include respiratory infections, cancers, kidney diseases, hypertension, pneumonia, and urinary tract infection. These diseases are growing in incidences due to population growth and people’s changing lifestyles.

Some of Medilines’ products are also used in the diagnosis and treatment of COVID-19 and its complications.

Medilines chairman Virgilio B. Villar said the company’s working relationship with the three global companies has been tested by time.

The strong partnership between Medilines and B. Braun Philippines started when the former distributed its dialysis products, surgical instruments, and other disposables since the day the company was founded in 2002.

B. Braun, a 182-year-old multinational medical device manufacturer from Germany, is one of the world’s leading providers of extracorporeal blood treatment. Their product portfolio in renal care includes dialysis machines and consumables consisting of dialyzers, bloodline systems, concentrates, fluid filter, cannula, and catheters.

Ever since its Avitum Division began dialysis center operations in the Philippines in 1989, B. Braun Avitum has been one of the top and most reliable brands of dialysis supplies and equipment in the country.

Backed with over 120 years of experience in the medical field and tens of thousands of patents globally, reputable German multinational company, Siemens Healthineers, meanwhile, is one of the leading medical technology companies in the world. Their product portfolio in diagnostic imaging includes CT scan, MRI, cathlab, C-arm, and X-ray, to name a few.

Siemens Healthineers has been Medilines’ partner since 2016. Through the principal’s then partnership and now integration with Varian Medical Systems, Siemens Healthineers has also been Medilines’ principal supplier of Varian linear accelerators used in the treatment of cancer. Varian Medical System is an American company that pioneers in the fields of advanced radiotherapy, radiosurgery, and many other vital cancer-fighting tools since 1937.

As one of the country’s established medical device distributors, Medilines is also looking forward to partner with other world-renowned brands in the future.

“We are always looking out for opportunities to serve more quality innovations to Filipinos and exploring business relationships with other promising medical device brands,” says Villar.

The Securities and Exchange Commission (SEC) has approved Medilines’ IPO in its pre-effective letter dated October 12. The PSE also gave its greenlight through its notice of approval dated October 18, subject to compliance with certain conditions.

Medilines will be listed under the trading symbol “MEDIC” upon the conclusion of the country’s first pure-play healthcare IPO.